This entity is known at euglycemic DKA and it is increasingly recognized for an association with a newer oral diabetic medication class, SGLT2 inhibitors
Clinical trials indicate it may produce greater weight loss than semaglutide, with additional metabolic benefits
The models used in CASSCF(14,13) calculations involving anions with charges of -2 or -3, such as reducing agents, are similar to those for singly charged anions
2 References 1 Weiss, Jessica B., et al
The goal is to provide accurate diagnosis and effective treatment while coordinating any necessary specialized care
But behind the hype, researchers in the burgeoning field of geroscience which seeks to understand the biology of aging have been investigating whether GLP-1 drugs like Ozempic and Zepbound do more than treat obesity and diabetes